Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic, and there is no standard and efficient therapy for it. Chitosan oligosaccharide (COS) is widely known to have various biological effects, and in this study we aimed to evaluate the liver-protective effect in diet-induced obese mice for a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Mar Drugs
मुख्य लेखकों: Qian, Minyi, Lyu, Qianqian, Liu, Yujie, Hu, Haiyang, Wang, Shilei, Pan, Chuyue, Duan, Xubin, Gao, Yingsheng, Qi, Lian-wen, Liu, Weizhi, Wang, Lirui
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6669476/
https://ncbi.nlm.nih.gov/pubmed/31269758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md17070391
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन